PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Otolaryngology-Head and Neck Surgery, Cedars Sinai, Los Angeles, CA, USA.\', \'Department of Otolaryngology-Head and Neck Surgery, Indiana University, Indianapolis, IN, USA.\', \'Department of Microbiology and Immunology, University of Louisville, Louisville, KY, USA.\', \'Division of Infectious Diseases, Departments of Internal Medicine and Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.\', \'Pharmacy Operations, Kindred Healthcare Support Center, Louisville, KY, USA.\', \'Department of Otolaryngology-Head and Neck Surgery and Communicative Disorders, University of Louisville, Louisville, KY, USA. thomas.higgins@louisville.edu.\', \'Rhinology, Sinus & Skull Base, Kentuckiana Ear, Nose, and Throat, Louisville, KY, USA. thomas.higgins@louisville.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/978-3-030-71697-4_14
?:doi
?:hasPublicationType
?:journal
  • Advances in experimental medicine and biology
is ?:pmid of
?:pmid
?:pmid
  • 34279838
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.867
?:rankingScore_hIndex
  • 104
is ?:relation_isRelatedTo_publication of
?:title
  • Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all